There is no Anthropic stock symbol yet

If you type “Anthropic” into your brokerage’s search bar, you will not find a ticker to buy. Anthropic is a private company, which means its shares are not listed on any exchange and there is no Anthropic stock name or symbol for retail investors to purchase. That single fact sits underneath everything in Alexander Green’s “Secret Backdoor to the REAL #1 Tech IPO of 2026” presentation in The Oxford Communiqué, because the whole pitch is built around a workaround for it.

Green’s solution is to point investors at two funds that hold Anthropic indirectly. Fundrise Venture trades under the ticker VCX, and Ark Venture trades under the ticker ARKVX. Neither is an Anthropic stock symbol, but both give you exposure to Anthropic shares through a fund wrapper, and that is the closest thing a retail investor can buy today.

VCX: the closed-end fund with the biggest stake

Fundrise Venture, trading as VCX, is the Fundrise Innovation Fund, a closed-end fund that listed on March 19, 2026 at roughly $19 net asset value. Its top holdings are Anthropic, Databricks, and OpenAI, with Anthropic as far and away the largest position. Because VCX is a closed-end fund, it trades on an exchange, and its price floats independently of the value of the assets it holds.

That independence cuts both ways. The fund’s net asset value is now estimated at $25 to $30, but the shares trade around $41, a 30 to 40 percent premium. The shares ran as high as $200 this spring, roughly ten times NAV, before lockup expirations brought them back. When you buy VCX, you are buying Anthropic exposure plus a markup, and that markup is the part most investors miss. Our Anthropic stock guide explains the trade in more detail.

ARKVX: the interval fund alternative

Ark Venture, trading as ARKVX, is Cathie Wood’s closed-end interval fund, and it holds Anthropic alongside SpaceX, OpenAI, and a wider basket of private technology names. Anthropic is roughly 4.3 percent of the fund, its fourth-largest position, with OpenAI larger. Unlike VCX, ARKVX prices at net asset value, so there is no premium to worry about.

The cost shows up elsewhere. ARKVX carries a 2.9 percent annual fee, a $500 minimum, and quarterly redemption caps of 5 percent, which limits how quickly you can exit. It is a cleaner price but a less convenient structure, and that trade-off is the whole ballgame when you are deciding between the two funds.

Why the name confusion keeps happening

The confusion is understandable. Anthropic is frequently in the news, its product Claude is everywhere, and investors reasonably assume a company this prominent must have a public ticker. It does not, at least not yet. Green expects an IPO announcement around September 29, 2026 at a San Francisco AI conference, and the company has filed a confidential S-1, so a real Anthropic stock symbol may arrive in the months ahead. Until then, VCX and ARKVX are the only practical ways for retail investors to get exposure, and both come with structural costs that deserve as much attention as the underlying company. For a look at how one of those funds actually works, see our Claude AI stock explainer.

The other tickers people confuse with Anthropic

The search for an Anthropic symbol leads investors to a handful of real tickers that hold it indirectly. Fundrise Venture (VCX) and Ark Venture (ARKVX) are the two Green names, but they are not the only ones. SK Telecom trades as SKM and holds a stake bought for about $100 million that may now be worth more than $2 billion. The Destiny Tech100 Fund trades as DXYZ, and the KraneShares Public-Private AI & Technology ETF trades as AGIX with roughly 2 percent in Anthropic. None of these is an Anthropic ticker, but each one is a place where a search for one tends to land.

What happens when the real symbol arrives

When Anthropic finally gets a public ticker, the entire backdoor trade re-rates. The closed-end fund premium on VCX is partly a scarcity premium, and scarcity disappears the moment the shares themselves can be bought directly. That is the scenario where the funds Green recommends can underperform even as Anthropic itself does well. Knowing there is no symbol today is useful; knowing what changes when the symbol appears is the part that actually protects you.

Why the name matters less than the price

Investors fixate on finding the ticker, but the ticker is the least important variable. Whether you buy Anthropic exposure through VCX, ARKVX, SKM, DXYZ, or AGIX, the outcome is determined by the price you pay relative to the underlying value, not by the symbol on the screen. VCX at a 30 to 40 percent premium is a different investment from ARKVX at net asset value, even though both hold the same company. Before chasing a name, do the arithmetic on the wrapper.

Ready to see the research? Click here to access Alexander Green’s report.

NewsletterVetter is an independent publication. We receive compensation from some of the services we review through affiliate links. Nothing on this site is investment advice. Always do your own research.